Literature DB >> 16270398

Ulcerative colitis in a multiracial Asian country: racial differences and clinical presentation among Malaysian patients.

Yan-Mei Tan1, Khean-Lee Goh.   

Abstract

AIM: Inflammatory bowel disease appears to be uncommon among Asians. This study was conducted to determine the prevalence of ulcerative colitis (UC) in Malaysian patients and to establish the spectrum of the disease seen in Malaysian patients. Three major Asian races: Malay, Chinese, and Indian co-exist in Malaysia and we sought to determine if there were any racial differences in the prevalence and presentation of disease. Racial differences for several other gastrointestinal diseases have previously been observed and found to be extremely interesting.
METHODS: Data were obtained retrospectively from a review of the medical records of in- and out-patients with a diagnosis of UC at the University Hospital, Kuala Lumpur between 1985 and 1998.
RESULTS: There were 45 confirmed cases of UC of which 3 were foreigners, who were excluded from analysis. Thirty new cases of UC were diagnosed during the study period. Their mean age at presentation was 33.0+/-10.0 years. The highest prevalence of UC was 17.9/100 000 hospital admissions in the Indians, followed by 11.2/100 000 hospital admissions in the Chinese. The lowest prevalence was 3.7/100 000 hospital admissions in the Malays. The prevalence of UC was significantly higher in the Indians and the Chinese when compared with the Malays with an OR of 4.89 (CI = 2.02-12.24; chi2 = 15.45, P<0.001) and 3.06 (CI = 1.24-7.78; chi2 = 6.30; P = 0.012) respectively. The extent of colonic disease was similar in the Malay and Indian patients. In contrast, distal or left-sided colitis predominated in the Chinese with an OR of 8.17 (95%CI = 1.31-64.87; chi2 = 5.53, P = 0.02). Extraintestinal manifestations were uncommon (11.9%).
CONCLUSION: UC is an uncommon disease in Malaysia, but racial differences exist. The Indians had the highest prevalence of UC with the Chinese demonstrating the least extensive disease.

Entities:  

Mesh:

Year:  2005        PMID: 16270398      PMCID: PMC4479689          DOI: 10.3748/wjg.v11.i37.5859

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  24 in total

1.  Inflammatory bowel disease in Iceland, 1990-1994: a prospective, nationwide, epidemiological study.

Authors:  S Björnsson; J H Jóhannsson
Journal:  Eur J Gastroenterol Hepatol       Date:  2000-01       Impact factor: 2.566

2.  Non-specific ulcerative colitis in Chinese and Indians in Singapore.

Authors:  W P Fung; E H Monteiro; J J Murugasu; K C Ng; K M Kho; S K Lee
Journal:  Med J Aust       Date:  1971-08-14       Impact factor: 7.738

3.  A study of the prevalence and clinical pattern of non-specific ulcerative colitis in northern India.

Authors:  B N Tandon; A K Mathur; L N Mohapatra; H D Tandon; K L Wig
Journal:  Gut       Date:  1965-10       Impact factor: 23.059

4.  Ulcerative colitis in Singapore: a clinical study of sixty-one patients.

Authors:  L B Teh; D Koh; H S Ng; K C Kwok; T C Lim; M S Ho; C S Seah
Journal:  Ann Acad Med Singapore       Date:  1987-07       Impact factor: 2.473

5.  Ulcerative colitis in the tropics.

Authors:  H K Chuttani; S P Nigam; S K Sama; P C Dhanda; P S Gupta
Journal:  Br Med J       Date:  1967-10-28

6.  Inflammatory diseases of the bowel: a Malaysian experience.

Authors:  T K Ti
Journal:  Aust N Z J Surg       Date:  1979-08

7.  Gastro-oesophageal reflux disease, reflux oesophagitis and non-erosive reflux disease in a multiracial Asian population: a prospective, endoscopy based study.

Authors:  Modh Said Rosaida; Khean-Lee Goh
Journal:  Eur J Gastroenterol Hepatol       Date:  2004-05       Impact factor: 2.566

8.  Ulcerative colitis in the Jewish population of southern Israel 1961-1985: epidemiological and clinical study.

Authors:  H S Odes; D Fraser; J Krawiec
Journal:  Gut       Date:  1987-12       Impact factor: 23.059

9.  Epidemiology of ulcerative colitis in western Norway.

Authors:  K Haug; E Schrumpf; S Barstad; G Fluge; J F Halvorsen
Journal:  Scand J Gastroenterol       Date:  1988-06       Impact factor: 2.423

10.  Ulcerative colitis in a North Indian hospital: current trends.

Authors:  M P Sharma; S K Sarin
Journal:  J R Coll Physicians Lond       Date:  1985-04
View more
  6 in total

Review 1.  Risk of colorectal cancer in Asian patients with ulcerative colitis: a systematic review and meta-analysis.

Authors:  Sawan Bopanna; Ashwin N Ananthakrishnan; Saurabh Kedia; Vijay Yajnik; Vineet Ahuja
Journal:  Lancet Gastroenterol Hepatol       Date:  2017-02-21

2.  Crohn's disease in adults: observations in a multiracial Asian population.

Authors:  Ida Hilmi; Y M Tan; K L Goh
Journal:  World J Gastroenterol       Date:  2006-03-07       Impact factor: 5.742

Review 3.  The Same Intestinal Inflammatory Disease despite Different Genetic Risk Factors in the East and West?

Authors:  Rashid N S Lui; Siew C Ng
Journal:  Inflamm Intest Dis       Date:  2016-07-15

4.  Indian Society of Gastroenterology consensus on ulcerative colitis.

Authors:  Balakrishnan S Ramakrishna; Govind K Makharia; Philip Abraham; Uday C Ghoshal; Venkataraman Jayanthi; Brij Kishore Agarwal; Vineet Ahuja; Deepak K Bhasin; Shobna J Bhatia; Gourdas Choudhuri; Sunil Dadhich; Devendra C Desai; Gopal Krishna Dhali; Bhaba Dev Goswami; Sanjeev K Issar; Ajay K Jain; Rakesh Kochhar; Ajay Kumar; Goundappa Loganathan; Sri Prakash Misra; C Ganesh Pai; Sujoy Pal; Anna Pulimood; Amarender S Puri; Ganesh N Ramesh; Gautam Ray; Shivaram P Singh; Ajit Sood; Manu Tandan
Journal:  Indian J Gastroenterol       Date:  2012-10-25

Review 5.  Inflammatory bowel disease and the South Asian diaspora.

Authors:  Affifa Farrukh; John Francis Mayberry
Journal:  JGH Open       Date:  2019-02-22

6.  Association of NOD1, CXCL16, STAT6 and TLR4 gene polymorphisms with Malaysian patients with Crohn's disease.

Authors:  Kek Heng Chua; Jin Guan Ng; Ching Ching Ng; Ida Hilmi; Khean Lee Goh; Boon Pin Kee
Journal:  PeerJ       Date:  2016-03-31       Impact factor: 2.984

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.